Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.

Gastroenterology - 1 Mar 1995

Olerup O, Olsson R, Hultcrantz R, Broome U

Abstract excerpt

BACKGROUND/AIMS: The association between primary sclerosing cholangitis (PSC) and the HLA haplotype A1, B8, DR3, DQ2 is well established. During the last few years, several additional HLA associations have been suggested in PSC. Furthermore, two different HLA-DR specificities have been reported to be markers for rapid disease progression. Our aim was to critically evaluate all of the current and as yet mostly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Biomarkers
Share to Codon

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Haplotypes

Share to HLA-DQ Antigens

Share to HLA-DR Antigens

Share to Phenotype

Source

Identifiers

PMID: 7875491
DOI: 10.1016/0016-5085(95)90463-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.PMID 7875491Read ↗

HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.Semantic proximity Read ↗

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.Semantic proximity Read ↗

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.Semantic proximity Read ↗

Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis.Semantic proximity Read ↗

Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.Semantic proximity Read ↗

Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.Semantic proximity Read ↗

HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.Semantic proximity Read ↗

Genetic epidemiology of primary sclerosing cholangitisSemantic proximity Read ↗

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.Semantic proximity Read ↗

Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis.Semantic proximity Read ↗

Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.Semantic proximity Read ↗

HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.